Isma Rana

698 total citations
9 papers, 61 citations indexed

About

Isma Rana is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Isma Rana has authored 9 papers receiving a total of 61 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in Isma Rana's work include Gastric Cancer Management and Outcomes (5 papers), Cancer Genomics and Diagnostics (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Isma Rana is often cited by papers focused on Gastric Cancer Management and Outcomes (5 papers), Cancer Genomics and Diagnostics (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Isma Rana collaborates with scholars based in United Kingdom, Italy and United States. Isma Rana's co-authors include Naureen Starling, Ruwaida Begum, David Cunningham, Ian Chau, Sheela Rao, Marco Gerlinger, David Watkins, Louise J. Barber, Annette Bryant and B Griffiths and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and BMC Cancer.

In The Last Decade

Isma Rana

8 papers receiving 60 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Isma Rana United Kingdom	5	31	29	27	22	19	9	61
Giby V. George United States	4	33 1.1×	45 1.6×	36 1.3×	17 0.8×	17 0.9×	15	66
Alex Northrop United Kingdom	2	32 1.0×	51 1.8×	29 1.1×	22 1.0×	32 1.7×	2	77
Sree B. Chalasani United States	6	38 1.2×	17 0.6×	26 1.0×	17 0.8×	24 1.3×	15	84
Vincenzo Guarini Italy	3	56 1.8×	19 0.7×	19 0.7×	25 1.1×	10 0.5×	4	69
Barbara Nutzinger United Kingdom	2	35 1.1×	58 2.0×	37 1.4×	28 1.3×	37 1.9×	3	86
Rachel de la Rue United Kingdom	2	19 0.6×	29 1.0×	32 1.2×	16 0.7×	51 2.7×	2	84
Eric Lander United States	4	24 0.8×	18 0.6×	32 1.2×	7 0.3×	36 1.9×	9	71
Laure Monard France	7	54 1.7×	14 0.5×	57 2.1×	17 0.8×	35 1.8×	14	96
Antonella Cammarota Italy	6	36 1.2×	12 0.4×	23 0.9×	22 1.0×	9 0.5×	18	77
Yasushi Rino Japan	6	34 1.1×	12 0.4×	39 1.4×	7 0.3×	33 1.7×	29	78

Countries citing papers authored by Isma Rana

Since Specialization

Citations

This map shows the geographic impact of Isma Rana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isma Rana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isma Rana more than expected).

Fields of papers citing papers by Isma Rana

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isma Rana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isma Rana. The network helps show where Isma Rana may publish in the future.

Co-authorship network of co-authors of Isma Rana

This figure shows the co-authorship network connecting the top 25 collaborators of Isma Rana. A scholar is included among the top collaborators of Isma Rana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isma Rana. Isma Rana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Slater, Susanna, Claire Saffery, Gillian Smith, et al.. (2024). Phase II trial of domatinostat (4SC-202) in combination with avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal adenocarcinoma: EMERGE. ESMO Open. 9(4). 102971–102971. 4 indexed citations

Slater, Susanna, Annette Bryant, Ruwaida Begum, et al.. (2023). ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C). BMC Cancer. 23(1). 257–257. 20 indexed citations

Gordon, Anderley, Andrew Woolston, Komel Khabra, et al.. (2023). Primary results of the ICONIC phase 2 trial of perioperative FLOT plus avelumab (FLOT-A) in operable oesophagogastric adenocarcinoma (OGA).. Journal of Clinical Oncology. 41(4_suppl). 446–446. 7 indexed citations

Rana, Isma, Edward W. Johnston, Alex Dunlop, et al.. (2022). 1253P Safety and efficacy of Wnt inhibition with a DKK1 inhibitor, DKN-01, in combination with atezolizumab in patients with advanced oesophagogastric adenocarcinoma: Phase IIa results of the WAKING trial. Annals of Oncology. 33. S1120–S1121. 2 indexed citations

Bryant, Annette, Ruwaida Begum, Michael Davidson, et al.. (2022). Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma: Results of the Proof-of-Concept iMYC Study. Current Oncology. 29(4). 2174–2184.

Starling, Naureen, Ian Chau, David Cunningham, et al.. (2021). Perioperative FLOT plus anti-PD-L1 avelumab (FLOT-A) in resectable oesophagogastric adenocarcinoma (OGA): Interim safety analysis results from the ICONIC trial.. Journal of Clinical Oncology. 39(3_suppl). 201–201. 9 indexed citations

Anandappa, Gayathri, Andrea Lampis, David Cunningham, et al.. (2019). Prospective analysis of microRNA 31-3p (miR31-3p) as a predictive biomarker of response to anti-epidermal growth factor receptor (anti-EGFR) monoclonal antibodies (mABs) in patients with metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 37(4_suppl). 548–548. 2 indexed citations

Davidson, Michael, Louise J. Barber, Andrew Woolston, et al.. (2019). Detecting and Tracking Circulating Tumour DNA Copy Number Profiles during First Line Chemotherapy in Oesophagogastric Adenocarcinoma. Cancers. 11(5). 736–736. 16 indexed citations

Khakoo, Shelize, Nicola Valeri, Thomas R. Jones, et al.. (2018). Circulating tumour DNA (ctDNA) as a tool to assess response and guide therapy adaptation in rectal cancer. Annals of Oncology. 29. viii661–viii661. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact